This session will provide an overview of the diagnosis and therapy of patients with GHD in adulthood focusing on diagnostic tests, hormone interactions and the monitoring of efficacy and safety.
1) Discuss the current recommendations when deciding what patients to test for GHD.
2) Review the validated tests for the diagnosis of GHD and their interpretation.
3) Consider the important interactions between GH with other hormone axes.
4) Assess strategies for evaluating efficacy and safety in long-term management.
*This activity is supported by an educational grant from Ascendis Pharma.